AlphaGrep UK Ltd Acquires New Stake in HCA Healthcare, Inc. $HCA

Key Points

• AlphaGrep UK Ltd acquired 2,767 HCA Healthcare shares during the second quarter, valued at approximately $1.08 million. Institutional ownership remains substantial, with hedge funds and other institutions holding 62.73% of the stock.
• HCA reported quarterly earnings of $7.59 per share, narrowly exceeding estimates, while revenue rose 8.7% year over year to $20.23 billion. Shares opened at $404.95, down 1.0%.
• HCA declared a quarterly dividend of $0.78 per share, representing an annualized payout of $3.12 and a 0.8% yield. Analysts maintain a “Moderate Buy” consensus, with an average price target of $462.64.

AlphaGrep UK Ltd acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 2,767 shares of the company's stock, valued at approximately $1,079,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HCA. BlackRock Inc. purchased a new stake in HCA Healthcare during the second quarter worth approximately $5,069,974,000. Norges Bank acquired a new position in HCA Healthcare during the 4th quarter valued at about $1,262,513,000. Legal & General Group Plc acquired a new position in shares of HCA Healthcare during the second quarter worth approximately $410,992,000. Jupiter Topco LLC bought a new position in shares of HCA Healthcare in the second quarter worth $371,138,000. Finally, Life Cycle Investment Partners Ltd acquired a new position in shares of HCA Healthcare during the fourth quarter valued at approximately $374,037,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Down 1.0%

Shares of HCA Healthcare stock opened at $404.95 on Friday. The firm's 50-day moving average price is $403.35 and its two-hundred day moving average price is $437.55. The company has a market capitalization of $87.67 billion, a price-to-earnings ratio of 13.56, a PEG ratio of 1.35 and a beta of 1.10. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare's revenue was up 8.7% compared to the same quarter last year. During the same period last year, the firm posted $6.84 earnings per share. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 10.45%.

Wall Street Analyst Weigh In

Several research firms have issued reports on HCA. Robert W. Baird dropped their price target on shares of HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating on the stock in a research report on Monday, July 27th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $435.00 target price on shares of HCA Healthcare in a research note on Monday, July 27th. TD Cowen dropped their price objective on HCA Healthcare from $500.00 to $431.00 and set a "buy" rating on the stock in a research note on Monday, June 22nd. JPMorgan Chase & Co. decreased their target price on HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating on the stock in a report on Thursday, August 20th. Finally, Mizuho decreased their price objective on shares of HCA Healthcare from $525.00 to $475.00 and set an "outperform" rating on the stock in a report on Tuesday, July 28th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source